There are many hundreds of papers on dendritic cell therapy vaccines in the medical literature. The numbers are increasing all the time.
Also the cancers involved are extending.
The first dendritic cell therapy vaccines were used in melanoma, which is a highly immunogenic tumour. Following that, there has been a range of papers on kidney cancers, prostate cancer, brain tumours, bowel cancers and on and on.
These approaches have been mostly used in Stage 3 and 4 cancers and have gone through Phase 2 clinical trials and some have gone through Phase 3 clinical trials.
No comments:
Post a Comment